Metabolomic Signatures in Doxorubicin-Induced Metabolites Characterization, Metabolic Inhibition, and Signaling Pathway Mechanisms in Colon Cancer HCT116 Cells

Doxorubicin (DOX) is a chemotherapeutic agent is used for various cancer cells. To characterize the chemical structural components and metabolic inhibition, we applied a DOX to HCT116 colon cancer cells using an independent metabolites profiling approach. Chemical metabolomics has been involved in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesan, Raja, Prabhakaran, Vasantha-Srinivasan, Valsala Gopalakrishnan, Abilash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694538/
https://www.ncbi.nlm.nih.gov/pubmed/36355130
http://dx.doi.org/10.3390/metabo12111047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694538/
https://www.ncbi.nlm.nih.gov/pubmed/36355130
http://dx.doi.org/10.3390/metabo12111047

Ejemplares similares